Evidence map›Paper›PMID 39985576›Full record

ArticleVirchows Archiv : an international journal of pathology2025

Sinonasal adenoid cystic carcinomas accompanied by seromucinous hamartoma and/or atypical sinonasal glands arising from seromucinous hamartoma: insight into their histogenesis.

Martina Bradová, Abbas Agaimy, Jan Laco, Petr Martínek, Stanislav Kormunda Ing, Cécile Badoual, Ivan Damjanov, Ilmo Leivo, Carlos E Bacchi, Eva Comperat and 9 more

Abstract read
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Martina BradováSikl's , Department of Pathology, Charles University, Faculty of Medicine in Plzen, E. Benese 13, 305 99, Pilsen, Czech Republic. bradova@biopticka.cz.ORCID http://orcid.org/0000-0002-5829-5572
Abbas AgaimyInstitute of Pathology, University Hospital Erlangen, Friedrich-Alexander University , Erlangen-Nürnberg (FAU), Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen, Germany.
Jan LacoThe Fingerland Department of Pathology, Charles University, Faculty of Medicine and , University Hospital Hradec Kralove, Czechia, Czech Republic.
Petr MartínekMolecular and Genetic Laboratory, Bioptic Laboratory, Ltd, Plzen, Czech Republic.
Stanislav Kormunda IngSikl's , Department of Pathology, Charles University, Faculty of Medicine in Plzen, E. Benese 13, 305 99, Pilsen, Czech Republic.
Cécile BadoualService d'Anatomo-Pathologie, Department of Pathology, Hôpital Européen G Pompidou, APHP, Université de Paris, 20-40 Rue Leblanc, 75015, Paris, France.
Ivan DamjanovDepartment of Pathology and Laboratory Medicine, The University of Kansas School of Medicine, Kansas City, KS, USA.
Ilmo LeivoInstitute of Biomedicine, Pathology, University of Turku, Turku, Finland.
Carlos E BacchiConsultoria Em Patologia, Botucatu, São Paulo, Brazil.
Eva ComperatDepartment of Pathology, Tenon Hospital, Sorbonne University, Paris, France.
Stephan Ihrler, Dermpath, Muenchen, Germany.
Niels J RuppDepartment of Pathology, and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
Radek ŠímaMolecular and Genetic Laboratory, Bioptic Laboratory, Ltd, Plzen, Czech Republic.
Petr ŠteinerMolecular and Genetic Laboratory, Bioptic Laboratory, Ltd, Plzen, Czech Republic.
Tomáš VaněčekMolecular and Genetic Laboratory, Bioptic Laboratory, Ltd, Plzen, Czech Republic.
Sarina MuellerDepartment of Otorhinolaryngology and Head and Neck Surgery, University Hospital Erlangen, Erlangen, Germany.
Sami VenteläDepartment of Otorhinolaryngology, Turku University Hospital, Turku, Finland.
Alena SkálováSikl's , Department of Pathology, Charles University, Faculty of Medicine in Plzen, E. Benese 13, 305 99, Pilsen, Czech Republic.
Michal MichalSikl's , Department of Pathology, Charles University, Faculty of Medicine in Plzen, E. Benese 13, 305 99, Pilsen, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathology of reactive, dysplastic, and neoplastic sinonasal seromucinous glands is complex, and their contribution to tumorigenesis of sinonasal carcinomas remains controversial. In our practice, we have observed the presence of respiratory epithelial adenomatoid hamartomas (REAH) and seromucinous hamartomas (SH) associated with adenoid cystic carcinomas (AdCC) in a subset of cases. In many of these cases, genuine atypical features and dysplastic characteristics of the glands were noted at the interface of SH and AdCC. To investigate this phenomenon further, 88 sinonasal AdCC cases were selected from the authors' files and analyzed histologically, immunohistochemically, and genetically searching for MYB/MYBL1 and NFIB gene fusions. HPV testing was also performed. Univariate statistical analysis was conducted on our cohort. Thirty-one cases (35%) showed features of atypical sinonasal glands arising in SH (ASGSH) at the SH-AdCC interface, characterized by bilayered epithelium, architectural disarray, mild nuclear polymorphism, and atypia, sometimes with colloid-like material in the lumen. The MYB immunomarker was negative in 14 ASGSHs (with a positive internal control in AdCC cells), while only two cases showed faint and moderate to weak expression of the antibody in ASGSH glands. In 12 cases, the immunostaining of ASGSH could not be properly assessed, while AdCC cells were negative. The immunostaining was not performed in five cases. Our findings suggest that a subset of sinonasal AdCC may originate in a multistep dysplastic process within SH, consistent with an SH-ASGSH-AdCC progression sequence.

Indexed as

Carcinoma, Adenoid CysticHamartomaParanasal Sinus NeoplasmsAdultAgedAged, 80 and overBiomarkers, TumorFemaleHumansImmunohistochemistryMaleMiddle AgedProto-Oncogene Proteins c-mybBiomarkers, TumorMYB protein, humanProto-Oncogene Proteins c-mybAdenoid cystic carcinomaAtypical sinonasal glands arising in seromucinous hamartomaMYBMYBL1NFIBRespiratory epithelial adenomatoid hamartomaSeromucinous hamartoma

Identifiers

PMID39985576
PMCPMC12213922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.